Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases

14Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.

Cite

CITATION STYLE

APA

Sun, M., Jiang, W., Mu, N., Zhang, Z., Yu, L., & Ma, H. (2023, December 1). Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases. Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-023-04203-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free